Board of management

With a total workforce of 56 highly qualified employees, our Mission is to help our customers succeed by providing reliable and high quality pharmaceutical products and services.

Martin Nicklasson

Chairman of The Board of Directors, Farma Investment AS (holding company) Read more about Martin

Chairman of the board of directors since 2011. M.Sc. Pharm. PhD and Associate Professor at the Faculty of Pharmacy, Uppsala University.
Other appointments: Chairman of the Board of Orexo and Zealand Pharma A/S. Board member of Basilea Pharmaceutica Ltd., PledPharma AB, BioInvent International AB and Biocrine AB. Member of the Royal Academy of Engineering Sciences (IVA).
Previous appointments: CEO at Swedish Orphan Biovitrum AB 2007-2010. Astra/AstraZeneca 1978–1989 and 1991–2007, among other responsible for global drug development and marketing and business development within AstraZeneca Ltd., and CEO of AstraZeneca Sweden AB. CEO of Astra Hässle AB and responsible for R&D within KAbi.

Hans Wikse

Member of The Board, Farma Investment AS (holding company) Read more about Hans

Hans is the Managing Partner at Procuritas and a board member of Team Olivia, Sonans, Farma Investment, Fidelix and Dantherm.

Prior to Procuritas (1998) Hans served as the Vice President of ABB in the Czech Republic responsible for M&A and restructuring. He has also worked at ABB in Switzerland where he firstly focused on corporate M&A activities and then worked as VP of marketing strategy and communications for the Power generation business. Prior to ABB Hans worked for McKinsey & Co and for Ericsson Telecom.

Hans holds an MBA from INSEAD, France and an MSc in Engineering Physics from the University of Uppsala.

DANIEL SCHUSS

Member of The Board, Farma Investment AS (holding company) Read more about Daniel

Daniel is a Director at Procuritas and a board member of Farma Investment and a deputy board member of Team Olivia.

Prior to joining Procuritas (2011), Daniel worked at Bain & Company in Stockholm as a management consultant. He has also worked as an analyst at the investment banking division of Goldman Sachs.

Daniel holds an MSc in Finance from the Stockholm School of Economics as well as an MSc in Industrial Engineering and Management from the Royal Institute of Technology in Stockholm. He has also spent one year as an exchange student at Columbia University in New York.

MATS PALMBLAD

Member of The Board, Farma Investment AS (holding company) Read more about Mats

Mats is the Managing Partner at PK Partners. Prior to joining PK Partners (2002), Mats was a Partner and Director of The Boston Consulting Group in London and Stockholm where he co-founded its Nordic operations and lead the Nordic Healthcare Practice (1989-2002). Mats’ experiences also include Baxter International in Chicago and Brussels (1986-1989).

Mats holds an M.Sc. in Engineering Physics from Lund University and an MBA from University of Chicago’s Graduate School of Business.

SVEN WALDENSTRÖM

Member of The Board, Farma Investment AS (holding company) Read more about Sven

Sven has a solid background with line positions as Managing Director and Marketing Director of a number of companies in industries such as retail and pharmaceuticals, in addition to Executive Search. He has also worked as a management consultant.

Sven has an MBA from the Stockholm School of Economics. Sven was while studying Chairman of the Swedish National Union of Students (SFS).

Contact

  • T: +47 21 60 87 00
    E: This email address is being protected from spambots. You need JavaScript enabled to view it.

    Karihaugveien 22
    N-1086 Oslo
    Norway